STAA Valuation

STAAR Surgical Co

Add to Watchlist

Advanced Chart

18.980

-0.31(-1.607%)1D

Overview
Forecast
Valuation
Earnings

STAA Relative Valuation

STAA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, STAA is overvalued; if below, it's undervalued.

Historical Valuation

STAAR Surgical Co (STAA) is now in the Undervalued zone, suggesting that its current forward PS ratio of 3.19 is considered Undervalued compared with the five-year average of 77.11. The fair price of STAAR Surgical Co (STAA) is between 23.24 to 92.62 according to relative valuation methord. Compared to the current price of 18.98 USD , STAAR Surgical Co is Undervalued By 18.33%.

Relative Value

Fair Zone

23.24-92.62

Current Price：18.98

18.33%

Undervalued

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

2.73

P/B

Median3y

6.05

Median5y

11.56

-3.46

FCF Yield

Median3y

0.04

Median5y

0.22

Competitors Valuation Multiple

The average P/S ratio for STAA's competitors is 3.92, providing a benchmark for relative valuation. STAAR Surgical Co Corp (STAA) exhibits a P/S ratio of 3.19, which is -18.70% above the industry average. Given its robust revenue growth of -44.94%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap